Ocuphire Pharma Income from Continuous Operations 2010-2024 | IRD
Ocuphire Pharma income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Ocuphire Pharma Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2023 | $-10 |
| 2022 | $18 |
| 2021 | $-57 |
| 2020 | $-25 |
| 2019 | $-6 |
| 2018 | $-14 |
| 2017 | $-25 |
| 2016 | $-9 |
| 2015 | $-14 |
| 2014 | $-19 |
| 2013 | $-9 |
| 2012 | $-6 |
| 2011 | $-11 |
| 2010 | $-14 |
| 2009 | $-3 |
| Ocuphire Pharma Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-8 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $6 |
| 2023-06-30 | $-5 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $34 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-39 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $-22 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $0 |
| 2014-03-31 | $-15 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-0 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-4 |
| 2010-12-31 | $-3 |
| 2010-09-30 | $0 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-8 |
| 2009-12-31 | $2 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-2 |
| 2009-03-31 | $-1 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |